Furthermore, the administration of CSF3-neutralizing antibodies resulted in a notable reversal of pulmonary fibrosis in IPF mouse models, supporting the hypothesis that CSF3 is a central mediator in the development and maintenance of fibrosis. Here, CSF3 is linked to pulmonary fibrosis.